Significance of fecal deoxycholic acid concentration for colorectal tumor enlargement

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 6, 2010, Pages 1541-1546

  Kawano, Atsuko ^a   Ishikawa, Hideki ^b   Kamano, Toshiki ^c   Kanoh, Motonari ^d   Sakamoto, Kazuhiro ^e   Nakamura, Tomiyo ^f   Otani, Toru ^g   Sakai, Toshiyuki ^b   Kono, Koichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Tokyo Rinkai Hospital   (Japan)

^d DAITO BUNKA UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY HOSPITAL   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Otani Clinic   (Japan)

Author keywords

Bile acids; Colorectal cancer; Deoxycholic acid; Prospective cohort study

Indexed keywords

EID: 79956088425     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Breuer NF, Dommes P, Jaekel S, et al (1985). Faecal bile acid excretion pattern in colonic cancer patients. Dig Dis Sci, 30, 852-9.
2. Haines A, Hill MJ, Thompson MH, et al (2000). A prospective study of faecal bile acids and colorectal cancer. Eur J Cancer Prev, 9, 317-23.
3. Hill MJ, Drasar BS, Williams REO, et al (1975). Fecal bile acids and clostridia in patients with cancer of the large bowel. Lancet, 1, 535-9.
4. Hori T, Matsumoto K, Sakaitani Y, et al (1998). Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats. Cancer Lett, 124, 79-84.
5. Imray CH, Radley S, Davis A, et al (1992). Faecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut, 33, 1239-45.
6. Ishikawa H, Akedo I, Otani T, et al (2005). Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer, 116, 762-7.
7. Kaibara N, Sasaki T, Ikeguchi M, et al (1983). Fecal bile acid and neutral sterols in Japanese with large bowel carcinoma. Oncology, 40, 255-8.
8. Kamano T, Mikami Y, Kurasawa T, et al (1999). Ratio of primary and secondary bile acids in feces: possible marker for colorectal cancer? Dis Colon Rectum, 42, 668-72.
9. Kozoni V, Tsioulias G, Shiff S, et al (2000). The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen. Carcinogenesis, 21, 999-1005.
10. Lapré JA, Van der Meer R (1992). Diet-induced increase of colonic bile acids stimulates lytic activity of fecal water and proliferation of colonic cells. Carcinogenesis, 13, 41-4.
11. Little J, Owen RW, Femandez F (2002). Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the Nottingham fecal occult blood screening trial. Dis Colon Rectum, 45, 1233-41.
12. Meance S, Boutron-Ruault MC, Myara A, et al (2003). Fecal primary bile acids and serum cholesterol are associated with colorectal adenomas. Dig Dis Sci, 48, 1751-7.
13. Mudd DG, McKelvey STD, Norwood W, et al (1980). Faecal bile acid concentrations of patients with carcinoma or increased risk of carcinoma in the large bowel. Gut, 21, 587-90.
14. Murray WR, Blackwood A, Trotter JM, et al (1980). Faecal bile acids and Clostridia in the etiology of colorectal cancer. Br J Cancer, 41, 923-8.
15. Ochsenkühn T, Bayerdörffer E, Meining A, et al (1999). Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer, 85, 1664-9.
16. Owen RW, Day DW, Thompson MH (1992). Faecal steroids and colorectal cancer: steroid profiles in subjects with adenomatous polyps of the large bowel. Eur J Cancer Prev, 1, 105-12.
17. Owen RW, Dodo M, Thompson MH, et al (1987). Fecal steroids and colorectal cancer. Nutr Cancer, 9, 73-80.
18. Owen RW, Henly PJ, Thompson MH, et al (1986). Steroids and cancer: faecal bile acid screening for early detection of cancer risk. J Steroid Biochem, 24, 391-4.
19. Peiffer LP, Peters DJ, McGarrity TJ (1997). Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro. Dig Dis Sci, 42, 2234-40.
20. Rafter JJ, Eng VW, Furrer R, et al (1986). Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon. Gut, 27, 1320-9.
21. Reddy BS, Mastromarino A, Wynder EL (1975). Further leads on metabolic epidemiology of large cancer. Cancer Res, 35, 3403-6.
22. Reddy BS, Watanabe K, Weisburger JH, et al (1977). Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res, 37, 3238-42.
23. Reddy BS, Wynder EL (1977). Metabolic epidemiology of colon cancer: fecal bile acids and neutral sterols in colon cancer patients and patients with adenomas polyps. Cancer, 39, 1533-9.
24. Roy P, Owen RW, Faivre J, et al (1999). Faecal neutral sterols and bile acids in patients with adenomas and large bowel cancer: an ECP case-control study. Eur J Cancer Prev, 8, 409-15.
25. Song S, Byrd JC, Koo JS, et al (2005). Bile acids induce MUC2 overexpression in human colon carcinoma cells. Cancer, 103, 1606-14.
26. Tanida N, Hasaka Y, Shimoyama T, et al (1984). Comparison of faecal bile acid profiles between patients with adenomatous polyps of the large bowel and healthy subjects in Japan. Gut, 25, 824-32.
27. Yang CX, Kuroishi T, Huang XE, et al (2002). Correlation between food consumption and colorectal cancer: an ecological analysis in Japan. Asian Pac J Cancer Prev, 3, 77-83.